ImmunityBio (IBRX) Gross Profit (2023 - 2026)
ImmunityBio (IBRX) posted quarterly Gross Profit of $44.0 million for Q1 2026, up 167.14% year-over-year from $16.5 million in Q1 2025, and up 16.0% quarter-over-quarter from $37.9 million in Q4 2025.
ImmunityBio (IBRX) Gross Profit (2023 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Gross Profit for 4 consecutive years, with $44.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Profit rose 167.14% year-over-year to $44.0 million; the TTM figure through Mar 2026 stood at $140.0 million (up 349.38% YoY), while the FY2025 annual figure was $112.5 million, up 663.21% from the prior year.
- Gross Profit advanced to $44.0 million in Q1 2026 per IBRX's latest filing, from $37.9 million in the prior quarter.
- Across five years, Gross Profit topped out at $44.0 million in Q1 2026 and bottomed at $40000.0 in Q1 2024.
- Historically, Gross Profit has averaged $14.3 million across 4 years, with a median of $6.8 million in 2024.
- Annual changes were most pronounced in 2025 — Gross Profit surged 41047.5% — and 2026, when it surged 167.14%.
- ImmunityBio's Gross Profit stood at $139000.0 in 2023, then jumped by 5333.09% to $7.6 million in 2024, then jumped by 401.89% to $37.9 million in 2025, then rose by 16.0% to $44.0 million in 2026.
- Business Quant data shows IBRX's Gross Profit at $44.0 million in Q1 2026, $37.9 million in Q4 2025, and $31.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | ImmunityBio | 7.97 Bn | 7.62 Bn | 50.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.94 Mn |
| Jun 30, 2026 | 50.94 Mn |
| Mar 31, 2026 | 43.97 Mn |
| Mar 31, 2026 | 43.97 Mn |
| Dec 31, 2025 | 37.90 Mn |
| Dec 31, 2025 | 37.90 Mn |
| Sep 30, 2025 | 31.88 Mn |
| Sep 30, 2025 | 31.88 Mn |
| Jun 30, 2025 | 26.29 Mn |
| Jun 30, 2025 | 26.29 Mn |
| Mar 31, 2025 | 16.46 Mn |
| Mar 31, 2025 | 16.46 Mn |
| Dec 31, 2024 | 7.55 Mn |
| Dec 31, 2024 | 7.55 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |